| Literature DB >> 31960619 |
Patrick Muchmore1, Shujing Xu1, Paul Marjoram1, Edward B Rappaport1, Jingying Weng1, Noa Molshatzki1, Sandrah P Eckel1.
Abstract
Exhaled nitric oxide (FeNO) is an established respiratory biomarker with clinical applications in the diagnosis and management of asthma. Because FeNO depends strongly on the flow (exhalation) rate, early protocols specified that measurements should be taken when subjects exhaled at a fixed rate of 50 ml/s. Subsequently, multiple flow (or "extended") protocols were introduced which measure FeNO across a range of fixed flow rates, allowing estimation of parameters including Caw NO and CA NO which partition the physiological sources of NO into proximal airway wall tissue and distal alveolar regions (respectively). A recently developed dynamic model of FeNO uses flow-concentration data from the entire exhalation maneuver rather than plateau means, permitting estimation of Caw NO and CA NO from a wide variety of protocols. In this paper, we use a simulation study to compare Caw NO and CA NO estimation from a variety of fixed flow protocols, including: single maneuvers (30, 50,100, or 300 ml/s) and three established multiple maneuver protocols. We quantify the improved precision with multiple maneuvers and the importance of low flow maneuvers in estimating Caw NO. We conclude by applying the dynamic model to FeNO data from 100 participants of the Southern California Children's Health Study, establishing the feasibility of using the dynamic method to reanalyze archived online FeNO data and extract new information on Caw NO and CA NO in situations where these estimates would have been impossible to obtain using traditional steady-state two compartment model estimation methods.Entities:
Keywords: Bayesian inference; FeNO; exhaled breath; sampling protocol
Mesh:
Substances:
Year: 2020 PMID: 31960619 PMCID: PMC6971414 DOI: 10.14814/phy2.14336
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
MAP point estimates and credible intervals across all scenarios for three subjects with FeNO50 at the 10th, 50th, and 90th percentiles
| Percentile | Scenario | CawNO | 95% CI of CawNO | CANO | 95% CI of CANO |
|---|---|---|---|---|---|
| 10 | 30 ml/s | 39.27 | (32.79, 46.36) | 5.94 | (4.57, 7.11) |
| 50 ml/s | 44.78 | (27.36, 63.17) | 3.35 | (1.83, 4.79) | |
| 100 ml/s | 20.42 | (1.78, 56.77) | 3.38 | (1.85, 4.24) | |
| 300 ml/s | 101.72 | (6.44, 161.44) | 0.62 | (0.05, 1.96) | |
| 3@50 | 46.73 | (40.43, 55.05) | 3.73 | (2.99, 4.30) | |
| HMA | 55.92 | (51.76, 60.44) | 1.91 | (1.57, 2.24) | |
| 9F | 57.31 | (54.45, 59.96) | 2.22 | (2.00, 2.47) | |
| 50 | 30 ml/s | 61.65 | (56.12, 67.34) | 8.90 | (7.62, 10.06) |
| 50 ml/s | 39.34 | (26.30, 53.28) | 9.53 | (8.18, 10.73) | |
| 100 ml/s | 10.42 | (1.08, 48.30) | 8.02 | (6.31, 8.53) | |
| 300 ml/s | 29.82 | (2.60, 140.77) | 2.68 | (0.94, 3.29) | |
| 3@50 | 48.87 | (42.58, 56.97) | 8.93 | (8.16, 9.54) | |
| HMA | 78.03 | (74.19, 81.80) | 4.53 | (4.20, 4.86) | |
| 9F | 79.87 | (77.38, 82.25) | 4.89 | (4.68, 5.14) | |
| 90 | 30 ml/s | 309.87 | (303.72, 316.44) | 12.93 | (11.65, 14.05) |
| 50 ml/s | 343.63 | (329.44, 356.58) | 12.07 | (10.81, 13.36) | |
| 100 ml/s | 254.04 | (223.50, 281.84) | 13.50 | (12.23, 14.82) | |
| 300 ml/s | 206.01 | (119.59, 293.91) | 7.56 | (6.20, 8.87) | |
| 3@50 | 358.29 | (349.07, 365.59) | 11.92 | (11.22, 12.70) | |
| HMA | 326.61 | (322.76, 330.41) | 9.30 | (8.96, 9.66) | |
| 9F | 337.54 | (335.83, 340.59) | 10.47 | (10.20, 10.65) |
Figure 1Performance comparison of simulation study results for all scenarios. (a) Distribution of errors as measured by the difference between MAP estimators and values of CawNO used in simulation. (b) Distribution of empirical standard deviation of the MCMC draws after burn‐in estimating CawNO. (c) Distribution of errors for CANO. (d) Distribution of empirical standard deviation for CANO
Figure 2Results from real data application. (a) Distribution of MAP estimates for CawNO. (b) Distribution of empirical standard deviation of the MCMC draws after burn‐in estimating CawNO. (c) Distribution of MAP estimators for CANO. (d) Distribution of empirical standard deviation for CANO
Spearman correlation of estimates for CawNO (upper triangular cells) and CANO (shaded lower triangular cells) across all scenarios using real data
| Scenario | 30 ml/s | 50 ml/s | 100 ml/s | 300 ml/s | 3@50 | HMA | 9F |
|---|---|---|---|---|---|---|---|
| 30 ml/s | 0.94 | 0.87 | 0.67 | 0.89 | 0.94 | 0.94 | |
| 50 ml/s | 0.81 | 0.89 | 0.73 | 0.94 | 0.90 | 0.92 | |
| 100 ml/s | 0.82 | 0.81 | 0.76 | 0.90 | 0.85 | 0.86 | |
| 300 ml/s | 0.65 | 0.70 | 0.76 | 0.71 | 0.67 | 0.68 | |
| 3@50 | 0.80 | 0.84 | 0.85 | 0.75 | 0.91 | 0.88 | |
| HMA | 0.81 | 0.77 | 0.81 | 0.78 | 0.85 | 0.99 | |
| 9F | 0.84 | 0.82 | 0.84 | 0.80 | 0.78 | 0.99 |
Figure 3(a) Distribution of absolute differences between MAP estimates of CawNO using two independent samples at the same flow rate. (b) Distribution of absolute differences between MAP estimates of CANO using two independent samples at the same flow rate
Figure 4Joint distribution of log1p transformed parameter estimates, and linear regression results relating 3@50 results to 9F estimates for (a) CawNO and (b) CANO